Extendicare (EXE) – Research Analysts’ Recent Ratings Updates

A number of firms have modified their ratings and price targets on shares of Extendicare (TSE: EXE) recently:

• 12/4/2025 – Extendicare was upgraded by analysts at BMO Capital Markets from a “hold” rating to an “outperform” rating. They now have a C$24.00 price target on the stock, up previously from C$21.00.
• 12/4/2025 – Extendicare had its price target raised by analysts at Canaccord Genuity Group Inc. from C$20.00 to C$22.50.
• 12/4/2025 – Extendicare was upgraded by analysts at Royal Bank Of Canada from a “hold” rating to a “moderate buy” rating. They now have a C$25.00 price target on the stock, up previously from C$15.00.
• 12/3/2025 – Extendicare was upgraded by analysts at Natl Bk Canada to a “strong-buy” rating.
• 12/3/2025 – Extendicare had its price target raised by analysts at Cormark from C$25.00 to C$30.00.
• 12/3/2025 – Extendicare had its price target raised by analysts at National Bankshares, Inc. from C$21.50 to C$24.50. They now have an “outperform” rating on the stock.
• 11/17/2025 – Extendicare had its price target raised by analysts at BMO Capital Markets from C$15.00 to C$21.00.
• 11/13/2025 – Extendicare had its price target raised by analysts at CIBC from C$18.00 to C$22.00.
• 11/13/2025 – Extendicare had its price target raised by analysts at TD Securities from C$15.00 to C$19.00.

Extendicare Announces Dividend

The company also recently disclosed a monthly dividend, which was paid on Monday, November 17th. Investors of record on Monday, November 17th were given a dividend of $0.042 per share. The ex-dividend date of this dividend was Friday, October 31st. This represents a c) annualized dividend and a yield of 2.3%. Extendicare’s dividend payout ratio is currently 46.60%.

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.